(Q40431109)

20 September 2017

1 reference

title

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins (English)

1 reference

20 September 2017

1 reference

1 reference

W. A. Craig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7587056

26 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7587056

26 May 2024

publication date

1 May 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:073288939500053D?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

https://api.elsevier.com/content/article/PII:073288939500053D?httpAccept=text/plain

26 May 2024

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Diagnostic Microbiology and Infectious Disease

26 May 2024

published in

1 reference

20 September 2017

volume

22

1 reference

20 September 2017

issue

1-2

1 reference

20 September 2017

page(s)

89-96

1 reference

Postantibiotic suppression of bacterial growth

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Postantibiotic effect of imipenem on Pseudomonas aeruginosa

26 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

26 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

The postantibiotic effect

26 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

26 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Clinical Pharmacokinetics of Cefotaxime in Patients with Normal and Reduced Renal Function

26 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design

26 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients

26 May 2024

12

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid

26 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli

26 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

26 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time

26 May 2024

16

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Cephalosporins — Cefotaxime 10 years later, a major drug with continued use

26 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Antibacterial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime

26 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Levels of cefotaxime in body fluids and tissues: a review.

26 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis

26 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats

26 May 2024

21

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

26 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

A problem in the interpretation of beta-lactam antibiotic levels in tissues

26 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid

26 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Comparative study of three different dosing regimens of cefotaxime for treatment of gram-negative bacteremia

26 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors

26 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Kinetics of antimicrobial activity

26 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

26 May 2024

28

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

In vivo postantibiotic effect in a thigh infection in neutropenic mice

26 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels

26 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

Penetration of eight beta-lactam antibiotics into the peritoneal fluid. A pharmacokinetic investigation

26 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0732-8893(95)00053-D

26 May 2024

Identifiers

1 reference

20 September 2017

1 reference